Explore
Validate
Learn
Other assayAntibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA1-711 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- VDR Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Description
- PA1-711 detects vitamin D receptor (VDR) from human, mouse and rat tissues.
- Concentration
- Conc. Not Determined
Submitted references Comparing the Expressions of Vitamin D Receptor, Cell Proliferation, and Apoptosis in Gastric Mucosa With Gastritis, Intestinal Metaplasia, or Adenocarcinoma Change.
The selective vitamin D receptor agonist, elocalcitol, reduces endometriosis development in a mouse model by inhibiting peritoneal inflammation.
Identification of a highly specific and versatile vitamin D receptor antibody.
Vitamin D receptor levels and binding are reduced in aged rat intestinal subcellular fractions.
Characterization of transcriptional activation and DNA-binding functions in the hinge region of the vitamin D receptor.
Identification and characterization of a response element in the EGFR promoter that mediates transcriptional repression by 1,25-dihydroxyvitamin D3 in breast cancer cells.
Immunochemical studies on the putative plasmalemmal receptor for 1, 25(OH)(2)D(3). I. Chick intestine.
Immunochemical studies on the putative plasmalemmal receptor for 1, 25(OH)(2)D(3). I. Chick intestine.
Chen LW, Chang LC, Hua CC, Cheng TC, Lee CC
Frontiers in medicine 2021;8:766061
Frontiers in medicine 2021;8:766061
The selective vitamin D receptor agonist, elocalcitol, reduces endometriosis development in a mouse model by inhibiting peritoneal inflammation.
Mariani M, Viganò P, Gentilini D, Camisa B, Caporizzo E, Di Lucia P, Monno A, Candiani M, Somigliana E, Panina-Bordignon P
Human reproduction (Oxford, England) 2012 Jul;27(7):2010-9
Human reproduction (Oxford, England) 2012 Jul;27(7):2010-9
Identification of a highly specific and versatile vitamin D receptor antibody.
Wang Y, Becklund BR, DeLuca HF
Archives of biochemistry and biophysics 2010 Feb 15;494(2):166-77
Archives of biochemistry and biophysics 2010 Feb 15;494(2):166-77
Vitamin D receptor levels and binding are reduced in aged rat intestinal subcellular fractions.
González Pardo V, Boland R, de Boland AR
Biogerontology 2008 Apr;9(2):109-18
Biogerontology 2008 Apr;9(2):109-18
Characterization of transcriptional activation and DNA-binding functions in the hinge region of the vitamin D receptor.
Shaffer PL, McDonnell DP, Gewirth DT
Biochemistry 2005 Feb 22;44(7):2678-85
Biochemistry 2005 Feb 22;44(7):2678-85
Identification and characterization of a response element in the EGFR promoter that mediates transcriptional repression by 1,25-dihydroxyvitamin D3 in breast cancer cells.
McGaffin KR, Chrysogelos SA
Journal of molecular endocrinology 2005 Aug;35(1):117-33
Journal of molecular endocrinology 2005 Aug;35(1):117-33
Immunochemical studies on the putative plasmalemmal receptor for 1, 25(OH)(2)D(3). I. Chick intestine.
Nemere I, Ray R, McManus W
American journal of physiology. Endocrinology and metabolism 2000 Jun;278(6):E1104-14
American journal of physiology. Endocrinology and metabolism 2000 Jun;278(6):E1104-14
Immunochemical studies on the putative plasmalemmal receptor for 1, 25(OH)(2)D(3). I. Chick intestine.
Nemere I, Ray R, McManus W
American journal of physiology. Endocrinology and metabolism 2000 Jun;278(6):E1104-14
American journal of physiology. Endocrinology and metabolism 2000 Jun;278(6):E1104-14
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 5 Digital images for different cell type of adenocarcinoma from 3 patients. Left: moderate differentiated adenocarcinoma, stage III. Middle: poor differentiated adenocarcinoma, stage I. Right: poor differentiated adenocarcinoma, stage III. From the top to the bottom: H&E stain, VDR, Ki67, CK18 stain processed by scanner and QuPath software.
